Stryker Corporation (SYK) Stock Analysis & Winston Score
Stryker makes medical equipment used in hospitals and surgery centers around the world. Its main products include artificial knees and hips, surgical robots, hospital beds, and trauma implants used to fix broken bones. It is one of the largest medical device companies in the world and owns the Mako surgical robot system, which is widely used in joint replacement surgeries. Stryker earns money by selling its devices and implants directly to hospitals and surgeons, and it also generates recurring revenue from software, service contracts, and replacement parts tied to its installed equipment. The company operates in over 75 countries, with the United States making up the majority of its sales. Its competitive moat comes from deep relationships with surgeons, a broad product portfolio, and the high switching costs once hospitals adopt its systems. The key growth driver is the aging global population, which is expected to increase demand for joint replacement procedures over the coming decades.
Winston Score: 63/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (15/30)
- Growth: Exceptional (17/20)
- Cash Flow: Exceptional (9/10)
- Stability: Good (6/10)
- Valuation: Good (6/10)
- Ownership: Good (8/15)
Key Facts
Price: $319.87
Market Cap: $122.6B
Sector: Healthcare
Industry: Medical - Devices


